This combination produced significantly lowering the mRNA expression of B-cell CLL/lymphoma (Bcl-2) and increasing the mRNA expression of Bcl-2-associated X protein (Bax), and Bax/Bcl-2 ratio, among other effects [97]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.